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Many studies have attempted to investigate the genetic susceptibility of Attention-Deficit/
Hyperactivity Disorder (ADHD), but without much success. The present study aimed to analyze both 
single-nucleotide and copy-number variants contributing to the genetic architecture of ADHD. We 
generated exome data from 30 Brazilian trios with sporadic ADHD. We also analyzed a Brazilian sample 
of 503 children/adolescent controls from a High Risk Cohort Study for the Development of Childhood 
Psychiatric Disorders, and also previously published results of five CNV studies and one GWAS meta-
analysis of ADHD involving children/adolescents. The results from the Brazilian trios showed that 
cases with de novo SNVs tend not to have de novo CNVs and vice-versa. Although the sample size is 
small, we could also see that various comorbidities are more frequent in cases with only inherited 
variants. Moreover, using only genes expressed in brain, we constructed two “in silico” protein-protein 
interaction networks, one with genes from any analysis, and other with genes with hits in two analyses. 
Topological and functional analyses of genes in this network uncovered genes related to synapse, cell 
adhesion, glutamatergic and serotoninergic pathways, both confirming findings of previous studies and 
capturing new genes and genetic variants in these pathways.
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In the last decade, multiple studies have investigated the genetic susceptibility for ADHD, most notably includ-
ing assessment of enrichment of copy number variation1–7. Genome-wide association studies (GWAS) of single 
nucleotide variants (SNVs) in ADHD have also been executed and a few variants of small or moderate effect 
sizes have been reported3,8,9. Despite these promising results, genes identified by GWAS (capturing CNVs and 
SNVs) still only contribute for a small percentage of the heritability of this complex trait10 and replication across 
these studies has been inconsistent11. This is likely attributed to the combination of modest effect sizes of caus-
ative mutations on disease susceptibility and underpowered studies due to small sample sizes. Meta-analyses in 
ADHD, while theoretically more powerful, has not succeeded in discovering novel loci7. However, copy-number 
variation (CNVs) analysis has been more successful than SNV analysis1,2,4,5,12–15.
Extensive literature has also emerged from the integration of different databases to prioritize variants of bio-
logical interest involving complex diseases such as psychiatric disorders16–20. In this regards, the public database 
ADHDgene (http://adhd.psych.ac.cn/) and reported a candidate ADHD gene list based on the overlap of five 
prioritization gene tools. Poelmans et al.19 used the results from five previous GWAS in ADHD to search for bio-
logical functions and pathways with the objective of reanalyze the results together. They performed a systematic 
literature searches for (putative) functions of the proteins coded by 85 consensus genes from GWAS.
Protein-protein interaction networks have more recently been shown to be of added value in: identifying new 
disease genes, studying their network properties, identifying disease-related sub-networks, and network-based 
disease classification21. The foundation for using data integration based on protein-protein interactions (PPI) data 
relies on the hypothesis that proteins related to the same diseases or phenotypes tend to interact or are closely 
located in the network22,23. Approaches using GWAS data and PPI networks have been published with focus on 
psychiatric disorders, including bipolar disorder16, schizophrenia17, autism18, as well as ADHD1,14. Elia and col-
leagues1 used PPI data to investigate networks with genes overrepresented in CNVs affecting multiple cohorts. 
They reported that CNVs in glutamate receptor family genes and in genes interacting with them were enriched 
in approximately 10% of cases, showing for the first time association of glutamate receptor genes with ADHD.
With the development of new genomic techniques to investigate changes in DNA, it has been possible to dis-
cover the genetic causes for a larger range of conditions and phenotypes than ever before. For some complex dis-
orders, it has been necessary to apply methods to analyze genome-wide variants with SNP arrays in conjunction 
with sequencing data to combine both common and rare variants24–26. Analysis of high throughput sequencing 
data has been successful in covering genomic regions with low frequency mutations, which also have impact in 
complex diseases14,25. Moreover different types of very rare variants, such as de novo variants, compound hete-
rozygosity and even heritable heterozygous missense variations have been shown to contribute to neurodevelop-
ment disorders27,28.
In other complex psychiatric disorders, such as autism29–31 and schizophrenia32,33, the role of common or 
inherited variants has been shown to be important. Small CNVs have also been reported34,35. These studies show 
that the genetic landscape of neurodevelopment psychiatric disorders can be composed by the combination of 
different types of variants.
According to Hawi et al.36, “As with other psychiatric disorders, the monogenic concept of ADHD has now 
been supplanted by a more plausible polygenic hypothesis where multiple risk genes (each of minor/modest 
effect) contribute to the etiology of the disorder. As detailed previously, ADHD-associated genes (and those 
showing trends towards association) are scattered through the genome but tend to be enriched within specific 
functional categories. This suggests that the emphasis on any individual candidate gene should be shifted to con-
sider a broader network view of biological pathways involving ADHD-implicated genes.”
As previously proposed by Girirajan and Eichler37, we have used in this present study both de novo and inher-
ited variants to integrate our model of ADHD genetic architecture using an exome analysis of 30 sporadic ADHD 
Brazilian trios and SNP-array from 503 typically Brazilian developed children. To validate our findings we inte-
grated our results with public ADHD genetic resources, gene expression data bases and PPI databases exploring 
the ADHD network in accordance to Hawi et al.36 and the hypothesis of network medicine described by Barabasi 
et al.22, that genes related to the same disease tend to interact.
Methods
In all analyses we only accepted variations in genes expressed in brain based on data from the Brain Span Atlas of 
the Developing Human Brain (http://brainspan.org), Brain Atlas (http://human.brain-map.org) and GTEx Portal 
(http://gtexportal.org). The analyses were conducted in 3 steps:
1. we used only data from Brazilian samples, searching for de novo and inherited SNVs and CNVs comparing 
ADHD trios and control samples to better explore the genomic architecture of our ADHD samples.
2. we constructed a protein-protein interaction network (PPI) based on all genes with SNVs and CNVs find-
ings by our work and studies with samples of children and adolescents reported by ADHDgene database 
(http://adhd.psych.ac.cn) and explore functional annotation of the network as well as topological proper-
ties of ADHD genes in the PPI network.
3. to achieve a highly reproducible ADHD gene set we selected only genes with two evidences: presented in 
our SNV and CNV analyses in different families or presented in our analyses and also in a previous GWAS 
or CNV public ADHD analyses. We used this gene set as seeds to growth a PPI.
A summary of steps 1 and 2 can be found in Fig. 1.
Brain expression data. The samples from Brain Span Atlas of the Developing Human Brain (http://brain-
span.org), Allen Human Brain Atlas (http://human.brain-map.org) and GTEx Portal (http://www.gtexportal.org) 
were used to understand what genes are expressed in brain. Genes with 1 reads per kilobase per million reads 
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(RPKM) in any area of the brain in at least one sample were considered expressed. After evaluation, our list con-
tained 54141 transcripts.
STEP 1 - Brazilian samples
The sample is part of the High Risk Cohort Study for Psychiatric Disorders in Childhood38, a two-stage large 
community study of children aged 6 to 12 years (at screening) from 57 schools in two Brazilian cities - Porto 
Alegre (n = 22) and São Paulo (n = 35). The ethics committee of the University of São Paulo approved the study 
and written consent from parents of all participants were collected. Detailed data could be found in Salum 
et al.38. Briefly, during the screening phase at their school registry day, 9,937 informants were interviewed. Two 
subgroups using a random-selection (n = 958) and high-risk group (n = 1,514) selection procedure that consisted 
of selecting individuals with high family loading of symptoms and ongoing psychiatric symptoms, were recruited 
resulting in a total sample of 2,512. Saliva was collected from all subjects and their parents. To establish child 
psychiatric diagnoses, the parent-reports of the Brazilian Portuguese version of the Development and Well-Being 
Assessment – DAWBA was performed by trained psychiatrists and to assess parent psychiatric diagnoses the Mini 
International Psychiatric Interview (MINI) and MINI Plus were used. Out of 2,512 subjects 240 met DAWBA cri-
teria for any ADHD, being 66 from the randomly selected group and 240 from the high-risk group. For the exome 
analysis, we selected 35 trios, in which the child was affected by ADHD and the parents were healthy as well as no 
familial history of ADHD was reported in the screening interview. A sub-sample of 724 subjects out of the 2,512 
was selected to collect blood and perform a functional magnetic resonance imaging (fMRI) study39. We used 503 
subjects from this sub-sample, in which the child was not affected by any DAWBA diagnosis and has available 
genotypes after quality control criteria using an SNP-array platform assay.
Exome data processing of Brazilian samples. The Nextera® Exome Enrichment Kit (Illumina Inc., San 
Diego, USA) was utilized to construct the libraries, which were prepared over a target region of 62 Mb, 20,794 
genes, 201,121 exons. The sequencing was performed using two technologies. In eight trios, Illumina HiScan 
SQ™ (Illumina, Inc.) was utilized. In 27 other trios, HiSeq 2500™ (Illumina, Inc.) was utilized. The reads were 
sequenced with the paired-end technique, producing in average 24 million reads per sample with length of 100bp, 
resulting in 2.4Gb sequenced per sample. The reads were mapped to National Center for Biotechnology Information 
(NCBI) reference human genome build 37 (GRCh37/hg19), using the software Burrows-Wheeler Aligner, or BWA 
(http://bio-bwa.sourceforge.net). These mapped reads were the input for Picard (http://broadinstitute.github.io/
picard) and GATK Unified Genotyper (https://www.broadinstitute.org/gatk) to find single-nucleotide variants 
through the best practices pipeline (https://www.broadinstitute.org/gatk/guide/best-practices) and calculate 
the exons coverage to run the program to identify CNVs. We used the software KING (http://people.virginia.
edu/~wc9c/KING) to check kinships between parents and children. It is expected that the value of the kinship 
between one parent and one child must be between 0.17 and 0.35. If the kinship is much lower than this value, it 
means that there is no relation of parenthood or that the samples might be contaminated. Trios with at least one 
kinship relation below 0.19 were removed from our analyses.
Figure 1. Summary of two first steps of the analyses performed in this work. The boxes in the topleft, in 
green, show the data the came from the exome analysis of Brazilian trios. The boxes in the top right, in yellow, 
show the data the came from previously reported findings in public databases. In the center and in the bottom, 
the blue elements show what was done with the combination of genes in both sets of data.
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Single-nucleotide variant (SNV) analysis in exome of Brazilian cases. Variants were annotated 
using Annovar (http://annovar.openbioinformatics.org) and SnpEff (http://snpeff.sourceforge.net), and databases 
dbSNP build 137 (http://www.ncbi.nlm.nih.gov/SNP/). We called ‘common’ the variants with maximum value 
minor allele frequency (MAF) greater than 5% in the ExAC database (http://exac.broadinstitute.org). Variants 
with at maximum MAF between 1% and 5% were called ‘rare’, ‘very rare’ if the maximum MAF was less than 1% 
and ‘novel’ if the variant was not found in the databases. After the annotation, we looked for three types of SNVs 
that could contribute to the disease: 1. de novo mutations with moderate and high impact (missense, nonsense or 
splice site); 2. rare, moderate impact (missense) homozygous mutations for loci where both parents are heterozy-
gous; and 3. very rare, high impact (nonsense and splice site) heterozygous mutations.
Copy-number variant (CNV) analysis in SNP array data of Brazilian healthy children. The sam-
ples were genotyped in HumanCore-12 v1.0 BeadChip (Illumina, Inc.), with 298,930 SNPs. We used PennCNV40 
to detect the CNVs in Brazilian control samples.
Copy-number variant (CNV) analysis in exome of Brazilian cases. We used XHMM (http://atgu.
mgh.harvard.edu/xhmm) to find copy-number variants in exome sequencing data. We selected only CNVs with 
at least 3 exons, minimum of 1kb, phred-scaled qualities of some CNV event in the interval and the quality of 
the region not being diploid were at least 90 and that were not present in Brazilian controls (SNP arrays data). 
We considered false positive and removed from the analysis CNVs present in more than three healthy parents, 
deletions with heterozygous SNVs rate above 10%, and duplications with average B allele frequency40 between 
0.4 and 0.6.
STEP 2 –Integration of Brazilian data with public databases and ADHD PPI network construction.
Single-nucleotide polymorphisms in public data. We used the set of genes related to the 50 result-
ing SNPs with P-value ≤ 10−5 from Neale et al.7 meta-analysis. This meta-analysis included only studies with 
children/adolescents and with the same categorical diagnostic variables, which decreases chances of phenotypic 
heterogeneity. All genes expressed in brain inside the CNV regions were considered.
Copy-number variants in public data. We also used the CNV studies from predominantly Caucasian 
samples of children/adolescents reported in the ADHDgene database. They are part of the following publica-
tions: Williams et al.5 (57 CNVs reported), Lesch et al.2 (17 CNVs reported), Lionel et al.4 (23 CNVs reported), 
Elia et al.1 (19 CNVs reported) and Jarick et al.15 (1 CNV reported). From the regions reported by these studies, 
we searched for genes that had an overlap with these regions, using package biomaRt (http://bioconductor.org/
packages/biomaRt). We converted all the regions to hg19 (version 19 of the human genome reference) positions 
using the package rtracklayer (http://bioconductor.org/packages/rtracklayer) of R language, which uses the same 
algorithm of UCSC genome browser (http://genome.ucsc.edu/cgi-bin/hgLiftOver). All genes expressed in brain 
inside the CNV regions were considered.
Protein-protein interaction data. To construct the PPI networks, we used the data from 
iRefIndex compilation (http://irefindex.org). This database is a union of the main PPI data-
b as es :  BIND (http : / /bind.ca) ,  BioGRID (http : / / t hebiog r id .org) ,  C ORUM (http : / /mips .
helmholtz-muenchen.de/genre/proj/corum), DIP (http://dip.doe-mbi.ucla.edu), HPRD (http://
hprd.org),  IntAct (http://www.ebi.ac.uk/intact) ,  MINT (http://mint.bio.uniroma2.it/mint), 
MPPI (http://mips.helmholtz-muenchen.de/proj/ppi)and OPHID (http://ophid.utoronto.ca). 
We selected only links supported by at least two pieces of direct experimental evidence demonstrating physical 
interaction between each pair of human proteins. The network was treated as an undirected graph. This final 
network has 73911 edges, representing protein-protein interactions, and 12464 nodes, representing genes/
proteins.
Network measures. In order to analyze the nodes and topological features, centrality measures (brokering 
centrality and betweenness centrality) and clustering coefficients were calculated41. The degree is the number of 
links of a node with other nodes (called neighbors) in the network. Nodes with very high degree are called hubs 
since they are connected to many neighbors. The removal of such nodes has great impact on the network topol-
ogy. It has been shown that biological networks tend to be robust against random perturbations, but disruption of 
hubs often leads to system failure. In this work, a measure called brokering centrality41 was used to identify hubs 
whose neighbors do not connect each other (or they connect less than expected). This measure uses the degree 
and the clustering coefficient to be calculated. The betweenness centrality is the measure of how a node is in the 
center of the network, and it shows important nodes that lie on a high proportion of paths between other nodes 
in the network. Proteins with high betweenness centrality have been termed “bottlenecks”, for their role as key 
connectors of proteins with essential functional and dynamic properties22. For a review of formulas of all these 
measures, see Cai et al.41. To compute nodes/genes measures, it was used the Python library NetworkX (http://
networkx.github.io). We calculated such measures for all the nodes in the network and classified the top 5% 
ranked for each measure as, respectively, brokers or bottlenecks.
Analysis of overrepresented pathways, biological functions, cytogenetic bands and diseases 
associated to the different sets of genes. To perform the enrichment analyses, the tool WebGestalt 
(http://bioinfo.vanderbilt.edu/webgestalt) was utilized. In this program, the set of genes in the human genome 
was used as reference, the corrections were made using Benjamini and Hochberg method, and only the top 10 
terms with an adjusted P-value less than 0.05 were considered significant for our analysis. For KEGG analysis, we 
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used the program STRING (http://string.embl.de), because the version was more updated (2014) than WebGestalt 
for KEGG (2011). For STRING, the Bonferroni correction was utilized in the adjustment.
STEP 3 – To achieve a highly reproducible ADHD gene set we selected only genes harboring probably delete-
rious variations presented by at least two evidences: presented in Brazilian SNV and CNV analyses of two differ-
ent families or presented in our analyses and also in a previous public analyses. Using only directed interaction 
to growth the seed genes considered highly reproducible we use the iRefIndex database (http://irefindex.org), to 
construct a PPI network and explore functional ontology of the network as already described above.
Results
Psychiatric disorders are considered polygenic and multifactorial, so today it is clear that both rare and common 
variation contribute to the genetic architecture of such diseases. In addition, it is also known that individuals 
from different families could have different variations for the same diseases42. For these reasons, stringent analysis 
criteria have been used, as comparison with public databases in the gene level, not in the variant level. On the 
other hand, various disorders hare the same genes, and one gene could participate in different processes, which 
leads us to believe that we should look at such diseases in a systemic view. One way to investigate it is by searching 
for biological networks and its topological properties, like clusters of genes and their biological functions, which 
could better explain genetic mechanisms of predisposition for a range of diseases or even for a specific disease. 
Following this idea, to prioritize genes and networks related to ADHD we present our results in three steps:
1. Analysis of individual variations in a specific population (SNV and CNV of Brazilian samples);
2. Integration of our data with public data in a gene level and analysis of such data in a systems biology approach, 
using protein-protein interaction networks of genes expressed in brain (Integrated PPI ADHD network);
3. Finding a highly reproducible ADHD gene set and the ADHD network.
To have a high reliability in each of these steps, the following criteria detailed in the method section were used:
In the first one we describe our exome results of 30 trios using high stringent criteria to variant call: target cov-
erage of 45× (average) and 50% of target regions with at least 20× of coverage. We removed trios with bad overall 
mapping quality and low values of kinship. Regarding overall single-nucleotide variants (SNVs), we removed var-
iants with less than 10 read depth or genes not expressed in brain. More specifically for de novo SNVs, we selected 
only moderate to high impact (nonsense, missense or splice site) SNVs. For copy-number variants (CNVs), we 
used an independent sample of healthy Brazilian children/adolescents and removed any CNVs also found in this 
sample. Besides applying the best practices of XHMM (a reliable software for CNV calling in exoma data)43, we 
developed a new method for removing false positive CNVs taking into account single-nucleotide variants (SNVs) 
for both deletions and duplications. Our method, inspired by PennCNV40 algorithm, performs a post-processing 
analysis checking the allele frequencies of SNVs in each CNV to remove those with a large difference of expected 
proportions.
In the second part we used data from public GWAS data exactly to find more confident results. Up to date, 
none of the previous GWAS studies performed in children and adolescents with ADHD was able to reach statis-
tical significance in genomic level. Although no variant reached significance, some findings show that common 
and rare variants could contribute to the disease. Given that, we decided to integrate our exome data results and 
public datasets of main genetic studies – including 50 SNPs from Neale et al.7 meta-analysis with P-value ≤ 10−5, 
and four studies that reported validated CNVs1,2,4,5 – all performed with children/adolescents having ADHD. 
Genes with no expression in brain, according to GTEx database, were removed.
In the third step, to achieve a highly reproducible ADHD gene set we selected only genes harboring probably 
deleterious variations presented by at least two evidences: presented in Brazilian SNV and CNV analyses of two 
different families or presented in our analyses and also in a previous public analyses. Using only directed interac-
tion to growth the seed genes considered highly reproducible we use the iRefIndex database (http://irefindex.org), 
to construct a PPI network and explore functional ontology of the network as already described above.
1. Analysis of individual variations in a specific population (SNV and CNV in Brazilian samples).
Single-nucleotide variants (SNV) analysis in the exome of Brazilian samples. Five trios were 
excluded from the analysis: one because the father sample did not pass the quality criteria of the sequencing pipe-
line, 3 trios because at least one kinship factor was less than 0.17 and one trio because both kinship factors were 
exactly at 0.17. Thirty trios remained in the analysis. We looked for three types of single-nucleotide variants that 
can be contributing to the disease:
(i)  De novo mutations with moderate and high impact (missense, nonsense or splice site): 26 variants were found 
in 25 genes, and all of them are expressed in brain (Table 1). In the gene VWDE two variants were found in 
the same family. One cytogenetic band presented hits in three different families: 19p13 (size: 20 Mb).
(ii)  Very rare, high impact (nonsense and splice site) heterozygous mutations (Sup. Table 2): 134 different variants 
were found in 134 genes expressed in brain. Six out of these 134 genes presented the same variant in two fam-
ilies: ACOXL, ANKRD42, CYFIP2, MSR1, NPSR1, OBSL1. The other 128 genes presented only one variant. 
Five cytogenetic bands presented hits in at least 4families: 3q13 (size: 89.7Mb), 5q33 (size: 10.1 Mb), 11p15 
(size: 21.7 Mb), and 19p13 (size: 20 Mb); and 19q13 (size: 26.7 Mb) presented hits in 10 families.
(iii)  Rare, moderate impact (missense) homozygous mutations for loci where both parents are heterozygous: 127 
different variants were found in 120 genes expressed in brain. Five genes (ACSM1, GIMAP6, ILDR1, MUC6, 
RGS12) presented two variants in the same family, one gene (IFLTD1) presented three variants in the same 
family and one gene presented (DNAH3) the same variant in two different families. The other 113 genes 
www.nature.com/scientificreports/
6Scientific RepoRts | 6:22851 | DOI: 10.1038/srep22851
presented only one variant. Two cytogenetic bands presented hits in 4 different families: 1p36 (size: 28 Mb) 
and 19q13 (size: 26.7 Mb). The other results are detailed in Sup. Table 3.
Copy-number variant (CNV) analysis in the exome of Brazilian samples. After mapping the reads 
to the Human genome (GRCh37/hg19), we used the XHMM software to call copy-number variations (CNVs). 
We found 13occurrences of putative CNVs in the Brazilian children, three being de novo CNVs, seven inherited 
exclusively from father and three inherited exclusively from mother. In these regions, 22 genes were found to be 
expressed in brain. The Sup. Table 1 has all CNVs found in the 30 trios. The gene TRIM48 (11q11) was found in 
a de novo and in an inherited CNV in two different children. We used the software BEDTools (http://bedtools.
readthedocs.org) to find the overlap and calculate the distances between CNV regions.
Analysis of SNVs and CNVs in the Brazilian trios. To investigate how inherited and de novo variants 
were distributed in the Brazilian children, we merged inherited SNVs and CNVs and compared it with de novo 
SNVs and de novo CNVs (Fig. 2). It is interesting to note that although our sample size is small we could observe 
that in average, children with only inherited variants, when compared to children with de novo variants, have two 
times more comorbidities. This is shown with more details in Sup. Table 4.
2. Integration of our data with public data in a gene level and analysis of such data in a systems biology approach, 
using protein-protein interaction networks of genes expressed in brain (Integrated PPI ADHD network).
Taking into account all the genes reported with SNP or in CNV in public databases or genes with SNV or in CNV 
in the Brazilian data, we ended up with a set of 1128 genes expressed in brain. We removed the olfactory receptors 
(total = 80) to avoid bias in the functional analysis. The final set has 1048 genes.
The GO analysis of these genes showed significant results for molecular function “ligand-gated ion channel 
activity” (GO:0015276), with 18 genes and adjusted P-value of 0.0093. The KEGG analysis showed significant 
results for “Neuroactive ligand-receptor interaction” (22 genes, adj. P-value = 9.63e–05), “Metabolic path-
ways” (50 genes, adj. P-value = 0.0015), “Calcium signaling pathway” (14 genes, adj. P-value = 0.0025), “Tight 
junction” (12 genes, adj. P-value = 0.0025), “Ubiquitin mediated proteolysis” (12 genes, adj. P-value = 0.0025), 
“Adherens junction” (8 genes, adj. P-value = 0.0056), “Cytokine-cytokine receptor interaction” (15 genes, 
adj. P-value = 0.0238). The cytogenetic bands significantly associated with ADHD were 15q11 (88 genes, adj. 
P-value = 1.30e–87, size = 6.7 Mb), 16p11 (70 genes, adj. P-value = 6.82e–55, size = 8.5 Mb), 7p15 (20 genes, adj. 
P-value = 8.26e–12, size = 7.9 Mb), 11q25 (10 genes, adj. P-value = 3.86e–08, size = 4.2 Mb), 4p15 (15 genes, adj. 
chr pos rsID band gene impact family frequency
1 2494330 rs2234167 1p36.32 TNFRSF14 NON SYNONYMOUS CODING NN2624 common
1 41296828 rs34287852 1p34.2 KCNQ4 NON SYNONYMOUS CODING NN2901 common
2 233537125 rs11550699 2q37.1 EFHD1 NON SYNONYMOUS CODING NN3752 common
3 193380726 rs200412464 3q29 OPA1 NON SYNONYMOUS CODING NN3506 very rare
4 169195114 . 4q32.3 DDX60 NON SYNONYMOUS CODING NN3506 novel
5 825280 rs1809008 5p15.33 ZDHHC11 NON SYNONYMOUS CODING NN1075 common
7 12409263 rs17165906 7p21.3 VWDE NON SYNONYMOUS CODING NN2624 common
7 12409327 rs17165910 7p21.3 VWDE NON SYNONYMOUS CODING NN2624 common
7 73969541 rs2301895 7q11.23 GTF2IRD1 NON SYNONYMOUS CODING 1659F common
9 87338590 . 9q21.33 NTRK2 NON SYNONYMOUS CODING NN3506 novel
9 101831995 rs10519 9q22.33 COL15A1 NON SYNONYMOUS CODING 1013F common
9 133577672 . 9q34.12 EXOSC2 NON SYNONYMOUS CODING NN3506 novel
9 139694569 rs7859194 9q34.3 KIAA1984 NON SYNONYMOUS CODING 1350F common
13 52544805 rs1801244 13q14.3 ATP7B NON SYNONYMOUS CODING NN2624 common
14 20249176 rs2815960 14q11.2 OR4M1 NON SYNONYMOUS CODING 1802F common
14 24629768 . 14q12 RNF31 NON SYNONYMOUS CODING 1013F novel
14 25043951 rs61737120 14q12 CTSG NON SYNONYMOUS CODING 691F rare
14 102391577 rs3742424 14q32.31 PPP2R5C NON SYNONYMOUS CODING 1732F common
15 90818469 rs12595409 15q26.1
NGRN (dist:3026) 
DQ582071 
(dist:18035)
STOP GAINED NN3506 common
17 7329310 . 17p13.1 C17orf74 SPLICE SITE ACCEPTOR 1372F novel
17 11784614 . 17p12 DNAH9 NON SYNONYMOUS CODING 1659F novel
18 61323012 rs3180227 18q21.33 SERPINB3 NON SYNONYMOUS CODING 894F common
18 61570529 rs6104 18q21.33 SERPINB2 NON SYNONYMOUS CODING NN3506 common
19 5691424 . 19p13.3 RPL36 NON SYNONYMOUS CODING NN3538 novel
19 8191184 rs35025963 19p13.2 FBN3 NON SYNONYMOUS CODING NN1075 common
19 17660300 rs11666267 19p13.11 FAM129C NON SYNONYMOUS CODING 1659F common
Table 1.  The 26 de novo single-nucleotide variants found in the trios exome sequencing data.
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P-value = 6.02e–08, size = 24.5 Mb), 15q12 (20 genes, adj. P-value = 2.69e–07, size = 2.4 Mb), 20p13 (15 genes, 
adj. P-value = 3.22e–07, size = 5.1 Mb) and 8q21 (16 genes, adj. P-value = 4.08e–07, size = 49.8 Mb).
To study how the genes were relatively located in the network space, we plotted a network with the genes 
related to ADHD and their direct interactions using protein-protein interaction databases. This network is com-
posed only of genes expressed in brain. Out of 1128 genes, only 557 were mapped in the interactome. Besides the 
557 seed genes, 2240 more genes were added to the network. The network is shown on Fig. 3.
3. Finding a highly reproducible ADHD gene set and the ADHD network.
To obtain a more robust view of the genes with SNVs and/or in CNVs, we selected genes with variants found in 
both the Brazilian exome data and public ADHD CNV data. Table 2 includes these 30 of the most significant and 
informative genes and which type of analyses they were derived from. All the other genes resulted from a single 
analysis.
Using only these 30 genes as seeds, we built a subnetwork adding the direct interactions to analyze which 
biological functions were associated with these genes. Out of 30 genes, only 15 were in the interactome. The final 
network ended up having 101 genes (Fig. 4). Using WebGestalt, we found gene ontology categories and protein 
modules over-represented in this network. Regarding cellular components, there are 13 genes related to neuron 
projection (adj. P-value = 6.00e–04), 5 genes related to cell-substrate adherens junction (adj. P-value = 3.00e–03), 
34 genes related to membrane-enclosed lumen (adj. P-value = 1.60e–03) and 14 genes related to synapse (adj. 
P-value = 7.80e–05). Moreover, the central nervous system genes are significantly connected in the network, 
according to WebGestalt analysis of protein modules (adj. P-value = 3.02e–05). Using STRING, we performed the 
enrichment analysis for KEGG and obtained the more specific synapse results: glutamatergic synapse (7 genes, 
adj. P-value = 3.28e–04) and serotoninergic synapse (6 genes, adj. P-value = 4.81e–03). This is shown in Table 3.
Gene
public 
CNVs
public 
SNPs
exome 
CNVs
exome 
SNVs band reference
ACOXL (acyl-CoA oxidase-like) no no no sv2c 2q13 59
ACSM1 (acyl-CoA synthetase medium-chain family member 1) no no no 2vsc 16p12.3 60
ANKRD42 (ankyrin repeat domain 42) no no no sv2c 11q14.1
CNGB3 (cyclic nucleotide gated channel beta 3) yes no no yes 8q21.3
CYFIP2 (cytoplasmic FMR1 interacting protein 2) no no no sv2c 5q33.3 61
CYP19A1 (cytochrome P450, family 19, subfamily A, polypeptide 1) yes no no yes 15q21.2
DDX60 (DEAD (Asp-Glu-Ala-Asp) box polypeptide 60) yes no no yes 4q32.3
DNAH3 (dynein, axonemal, heavy chain 3) no no no sv2c 16p12.3
DNHD1 (dynein heavy chain domain 1) yes no no yes 11p15.4
EMP2 (epithelial membrane protein 2) yes yes no no 16p13.13 62
GIMAP6 (GTPase, IMAP family member 6) no no no 2vsc 7q36.1
GOLGA8DP (golgin A8 family, member D, pseudogene) yes no yes no 15q11.2
HEATR1 (HEAT repeat containing 1) yes no no yes 1q43
IFLTD1 (lamin tail domain containing 1) no no no 3vsc 12p12.1
ILDR1 (immunoglobulin-like domain containing receptor 1) no no no 2vsc 3q13.33
ITGA3 (integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)) yes no no yes 17q21.33
MSR1 (macrophage scavenger receptor 1) no no no sv2c 8p22
MUC6 (mucin 6, oligomeric mucus/gel-forming) no no no 2vsc 11p15.5
NPSR1 (neuropeptide S receptor 1) no no no sv2c 7p14.3
OBSL1 (obscurin-like 1) no no no sv2c 2q35
OR8K3 (olfactory receptor, family 8, subfamily K, member 3) yes no no yes 11q12.1
PPP6R3 (protein phosphatase 6, regulatory subunit 3) yes no no yes 11q13.2
RGS12 (regulator of G-protein signaling 12) no no no 2vsc 4p16.3 63
SDK1 (sidekick cell adhesion molecule 1) yes no no yes 7p22.2
SMYD3 (SET and MYND domain containing 3) yes no no yes 1q44
TRIM22 (tripartite motif containing 22) yes no no yes 11p15.4
TRIM48 (tripartite motif containing 48) no no sv2c no 11q11
TRIML2 (tripartite motif family-like 2) yes no no yes 4q35.2
UQCRC2 (ubiquinol-cytochrome c reductase core protein II) yes no no yes 16p12.2 56
VWDE (von Willebrand factor D and EGF domains) no no no 2vsc 7p21.3
Table 2.  Genes with hits in at least two categories of variants found from Brazilian samples exome and 
from public data. The type of analysis is highlighted with a grey background. All genes are protein coding. 
The only exception is GOLGA8DP, which is a transcribed unprocessed pseudogene, and OR8K3, which is a 
polymorphic pseudogene. Legend: sv2c: same variant in 2 children; 2vsc: 2 variants in the same child. In the last 
column we could observe references of association of the gene and other neurodevelopment disorder.
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Discussion
Despite a 70% to 80% heritability estimate44, finding gene variants associated with the ADHD phenotype has been 
extremely challenging. Some genes seem to be more related to the susceptibility of any psychiatric neurodevel-
opmental disorder but the complexity of combinations of non-specific variations with more individual ones and 
the environment will bring the colors of a specific disorder45. With this idea, we explored different types of genetic 
variations using ADHD trios exome data. An intuitive method to find variations related to a disorder is to look for 
de novo variants in trios where the parents do not have ADHD and the children show the phenotype. Such vari-
ants have been shown as potential causes of several psychiatric diseases12,13,34,46. Here we found 26 de novo SNVs 
with moderate and high impact in 25 brain-expressed genes in 14 different families and three de novo CNVs in 
different families. Although combining exome and GWAS studies has some technical limitations, studies in the 
literature have demonstrated the effectiveness of using combined analysis methods47. To search CNVs related to 
ADHD, it is important to mention that we compared in this present study the copy-number variants found in 
the Brazilian trios using whole-exome data combined with CNV regions found in 503 Brazilian controls using 
SNP-array data. The intention was to remove any CNVs that are present in controls from the analysis.
However, it also has been shown that rare inherited variants35 play an important role in other neurodevel-
opment disorders37. Assuming that ADHD should not be different from other neurodevelopmental disorders, 
we searched for inherited SNVs and CNVs. Regarding SNVs, we found 127 rare, moderate impact (missense) 
homozygous mutations for loci where both parents are heterozygous in 120 reported genes expressed in brain, 
suggesting a possible recessive heritability in ADHD as has been suggested for autism48. Besides that, 134 very 
rare, high impact (nonsense and splice site) heterozygous mutations were found in 134 genes expressed in brain. 
Regarding structural variants, we found 10inherited CNVs that were not present in Brazilian controls. Although 
we found putative CNVs inherited more from father than from mother, the limitation of our small sample size 
makes difficult to assert that this is a recurring pattern.
Regarding the variants found only in the Brazilian cases, it was observed that usually it was necessary the 
combination of exclusively inherited variants or inherited variants with a few de novo variants. Interestingly, the 
children who presented de novo SNVs did not present de novo CNVs, and vice-versa (only one child is an excep-
tion, with one de novo CNV and one de novo SNV). This corroborates what has been shown in other psychiatric 
diseases37, such as autism29–31, schizophrenia32,33, and bipolar disorder49. In these diseases, the studies reported 
the role of de novo and inherited variants, as well as common and rare variants. Particularly in ADHD, Yang 
and colleagues14 performed a case-control analysis using SNP-array approach (Affymetrix 6.0) of a large cohort 
of Chinese subjects aiming to discover both common and rare variants associated with ADHD. Although they 
GO id Term
no. of 
genes p-value
p-value 
Bonferroni
4810 Regulation of actin cytoskeleton 11 6.59E–09 1.89E–06
4730 Long–term depression 7 1.42E–08 4.07E–06
4915 Estrogen signaling pathway 8 1.92E–08 5.51E–06
5016 Huntington’s disease 9 2.83E–07 8.11E–05
4724 Glutamatergic synapse 7 1.14E–06 3.28E–04
4540 Gap junction 6 3.46E–06 9.93E–04
4723 Retrograde endocannabinoid signaling 6 8.07E–06 2.32E–03
4720 Long–term potentiation 5 1.49E–05 4.27E–03
4726 Serotonergic synapse 6 1.67E–05 4.81E–03
Table 3.  KEGG pathways significant after Bonferroni Correction using STRING.
Figure 2. Barplot with percentages of inherited and de novo variants (divided in CNVs and SNVs) in 
Brazilian children found in our whole exome analysis. 
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did not find genome-wide significant results, they could point some biological pathways using network analysis 
integrating the genes with higher association. More recently, Martin and colleagues50 used UK-based children 
samples to test whether children with ADHD with large rare CNVs had different polygenic risk scores (based 
on SNPs) for ADHD when compared to children with ADHD without these CNVs. In other words, their results 
implied that comparing children with a large, rare CNV with children without, the former require less of a poly-
genic burden to develop the disease, when we look at the SNPs in these children. However, our exome data made 
possible to look at smaller CNVs, and we also found CNVs with less than 100kb that could be playing a role in 
the disease.
When we combined the variants found in CNVs or SNVs taking into account the findings in our exome data 
and in the public databases of children with ADHD, the results highlighted interesting biological functions and 
diseases significantly associated to ADHD. For example, the GO molecular function and KEGG exhibited terms 
related to activity of cells in brain, as “ligand-gated ion channel activity”, of which some genes have been studied 
as therapeutic targets for ADHD, Alzheimer’s disease, schizophrenia, depression and tobacco addiction. Other 
pathways found have already been related to ADHD. The most significant were “Neuroactive ligand-receptor 
interaction” (the ADHDgene database reports 89 genes), “Calcium signaling pathway” (66 genes on ADHDgene) 
and “Cytokine-cytokine receptor interaction”. So far genes involved in synaptogenesis and calcium channels have 
been consistently described in the literature51,52. Some of the chromosome regions overrepresented have been 
described, but only region 11q25 were in the top regions on ADHDgene database suggesting that our network 
analysis could be contributing with new candidate genes related to ADHD. More interesting in the network anal-
yses, is the topological properties of ADHD genes. Cai and colleagues41 revealed that genes related to diseases 
tend to be brokers, and this property keeps robust even with the literature bias present in the interactome. Further 
studies revealed that gene properties in a network are different in autosomal or complex disorders and also that 
different kinds of genetic variation are related to specific topological areas of the network22. It is interesting to 
observe that the nodes related to ADHD SNVs or CNVs are not central or highly connected as expected for a 
complex disease. Although they are linked to such nodes, they are located in the borders of the network. This 
fact supports that the impact of such variants, separately, is not severe. In contrast, it is necessary a combination 
of factors to trigger the development of the disease. Together with their interactions, the genes with SNVs or in 
CNVs make complexes related to important biological functions.
Promising results came up when only genes recurrent in at least two different analyses and their direct inter-
actions on PPI databases have been used, since the connections in the neighborhood of these genes could show 
pathways with more confidence. Some of our seed genes have already been associated with other neurodevelop-
mental disorders such as schizophrenia and autism. It is important to note that Cytoplasmic FMR1-interacting 
Figure 3. Network created with genes related with ADHD and the direct neighbor protein on PPI 
databases. The genes with blue borders are the seeds. The genes in orange are brokers or bottlenecks. Only 5.5% 
of the seeds are central (highly connected nodes).
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protein 2 (CYFIP2) was identified as an interaction of FMRP, clearly related to Autism. Importantly, CYFIP2 is a 
component of WAVE regulatory complex, a key regulator of actin cytoskeleton. Han and colleagues53 showed that 
CYFIP2 could be implicated in the dendritic spine regulation in cortical neurons and suggest that misregulation 
of CYFIP2 function and its mGluR-induced expression contribute to the neurobehavioral phenotypes of FXS. 
OBSL1 is important for the regulation of a signaling mechanism that orchestrates the morphogenesis of the Golgi 
apparatus and pattern of dendrites54. Interestingly NPSR1 and UQCRC2 seem to be more specific for ADHD. 
NPSR1 modulated by calcium signaling pathways has been involved in Modulation of prefrontal functioning 
in attention systems and motor impairments55 and UQCRC2 has been related to methylphenidate treatment56.
Yang and colleagues14 also combined CNVs and SNPs to study ADHD. Their study, which also used networks 
to investigate the role of different types of variants, reported synapse (15 genes) and neuron projection (16 genes) 
as GO (Cellular component) terms associated with regulatory regions. Interestingly, although we confirmed these 
categories, the overlap of genes is very low – only gene CNTN2 is in both analyses. Analyzing the enriched path-
ways, we found genes significantly related to “glutamatergic synapse”, as well as “Serotonergic synapse”. Elia and 
colleagues1 reported networks with genes related to glutamatergic neurotransmission that were affected by CNVs 
in multiple cohorts. These findings were replicated by Akutagava-Martins and colleagues57 in Brazilian sam-
ples, which supports the role of glutamate in ADHD. Regarding the glutamatergic pathway genes, our approach 
also discovered genes not reported by these previous studies in ADHD: PLCB1, PLCB3, GNAI2, GNAI3 and 
CACNA1A.
In addition to the small sample size, as a limitation of our study, admixed population such as the one from 
Brazil brings some particularities to the analyses58. In this scenario we used as much data integration as possible. 
Albeit our results confirm the disruption of pathways already associated to ADHD, it also confirms the com-
plexity and heterogeneity of the disease, showing that in different patients, families or populations, disruption in 
different genes can be conducing to the development of the disease.
In conclusion, using an innovative data integration using public data and the first exome analysis performed 
in sporadic ADHD trios, we found other genes related to biological pathways previously reported in literature. 
Although our results confirmed findings published by other research groups, further analyses are essential to con-
firm the hypotheses and biological functions in larger and different populations. The analyses made exclusively 
with exome data showed a balance in inherited and de novo events, separating in three groups probands without 
any de novo variant, probands with de novo CNVs and those who had de novo SNVs, and also from children only 
with inherited variants. This could confirm the role of such variations in ADHD, but further work is necessary 
to find answers in non-coding regions/regulatory elements in the human genome, as well as the genes in the PPI 
network affect the processes involved in the disease.
Figure 4. Network with genes in at least two analyses (seeds, which are the blue nodes) and their direct 
interactions (grey nodes). 
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